Western Companies Pfizer updated its public R&D pipeline on 4 November 2025, highlighting late-stage vaccine assets (including RSV, meningococcal, and next-generation COVID products) while signaling a more selective...
According to the WHO Global Vaccine Market Report 2024 and supporting financial data from major pharmaceutical rankings and peer-reviewed analyses, the following twelve companies accounted for the most global human...
Chikungunya virus disease risk in Europe is rising sharply in 2025, with locally acquired cases now confirmed in both France and Italy, and record numbers of outbreaks attributed to the spread and establishment of Aedes...
A recent surge in infections across Latin America has propelled the Oropouche virus, an arbovirus long considered a marginal health threat, into the global spotlight. Like dengue and Zika, Oropouche virus (OROV) causes...
The Latin American Society of Pediatric Infectology (SLIPE for its acronym in Spanish) is working hard to strengthen the vaccination recommendations as the most effective method to prevent meningococcal disease, a...